II
INSPERITY, INC. (NSP)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 revenue rose 2% year over year to $1.613B as higher pricing offset a 2% decline in average WSEEs; GAAP diluted EPS was $(0.22) and adjusted EPS was $0.05, with adjusted EBITDA of $23M .
- Results were above the midpoint of company guidance: Q4 adjusted EPS $0.05 vs prior guidance range $(0.10)–$0.12 and adjusted EBITDA $23M vs $15–$27M; management also noted Q4 adjusted EPS/EBITDA were above the midpoint of its expected range on the call .
- Management highlighted a “growth inflection point” entering 2025 driven by a record fall sales/retention campaign: WSEEs paid from new clients +37% y/y in Q4, client retention ~99%, and January WSEEs turning positive year over year; mid‑market attrition improved sharply (down 63% vs 2024 in large accounts) .
- 2025 guidance: Q1 adjusted EPS $1.89–$2.15; FY adjusted EPS $3.10–$3.95; Q1 adjusted EBITDA $121–$135M; FY $240–$285M; WSEEs +2% to +4% for the year; guidance assumes higher medical cost trend (5%–6.5%) and ~$62M Workday spend .
- Catalysts: Workday partnership milestones (corporate tenant go‑live targeted for April 1), sustained WSEE growth, and pricing discipline; watch benefits cost trend and tax rate headwind (~$0.06 EPS impact in Q1/FY 2025) .
What Went Well and What Went Wrong
What Went Well
- Record fall sales/retention campaign drove momentum: “record‑setting quarter in booked sales, up 8%,” WSEEs from new clients +37% y/y in Q4, and ~99% client retention; January turned to positive y/y WSEE growth, creating an inflection point entering 2025 .
- Pricing power held: gross profit per WSEE $235/month “slightly above expectations” in Q4 on strong pricing; full‑year pricing and favorable H1 benefits claims lifted gross profit +1% despite lower WSEEs .
- Workday partnership progressing: corporate tenant targeted for April 1; expected platform updates in March/September; early signs of mid‑market retention benefit with large‑account attrition markedly lower .
What Went Wrong
- Client hiring remained weak in Q4, keeping paid WSEEs down 2% y/y to 309,093 and limiting gross profit dollars (down 2% y/y to $218M) despite stable GP per WSEE; operating expenses rose 17% y/y, including ~$19M Workday costs, driving a GAAP net loss .
- Q4 GAAP diluted EPS swung to a loss of $(0.22) vs $0.52 y/y; adjusted EPS fell to $0.05 vs $0.75; adjusted EBITDA fell to $23M vs $56M y/y as opex and normalizing benefits costs weighed on margins .
- Management’s 2025 outlook assumes benefits cost trend at high end of historical (5%–6.5%) and a higher tax rate, creating near‑term EPS pressure (about $0.06 headwind to Q1/FY 2025) while Workday implementation spend increases to ~$62M .
Financial Results
Notes: Q4 2024 adjusted EPS/EBITDA exceeded the midpoint of company’s Q4 guidance ranges (EPS $(0.10)–$0.12; EBITDA $15–$27M) . Management stated Q4 adjusted EPS/EBITDA were above the midpoint of expectations on the call .
KPIs
Estimates vs. Actuals
- Wall Street consensus (S&P Global) for Q4 2024 EPS and revenue was not available at the time of analysis due to an SPGI rate limit; therefore, we cannot present a vs‑consensus comparison today. Where estimates are required, values were unavailable from S&P Global at this time.
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We achieved this goal… moving our year‑over‑year growth rate from a negative in Q4 to a positive in January, reestablishing growth momentum entering 2025.” – CEO Paul Sarvadi on the fall campaign inflection .
- “Gross profit per worksite employee in Q4 was $235 per month, slightly above our expectations, primarily due to strong pricing.” – CFO Jim Allison .
- “The improvement was so dramatic, 62% better than last year… in our larger account segments… just shows you an early signal.” – CEO on mid‑market retention improvement linked to Workday interest .
- “We are pleased to announce the Insperity corporate tenant is scheduled for a launch date of April 1… a big step in the right direction for the exclusive client tenant.” – CEO on Workday milestones .
- “We are forecasting a benefits cost trend of 5% to 6.5% compared to 4.3% in 2024… operating plan… essentially flat compared to 2024… Workday spend ≈$62M in 2025.” – CFO on 2025 assumptions .
Q&A Highlights
- Workday partnership: Lead flow expected to ramp once co‑selling, incentives, and training align; early proof points include specific clients lined up for beta, aiding retention in large accounts .
- Expense cadence: Workday implementation costs expected to be relatively steady through 2025, with slight drop after corporate component completion; 2026 spending depends on launch timing .
- Pricing vs medical trend: Management believes pricing remains competitive despite higher medical trends; expects to match price to cost while maintaining premium positioning .
- Sales optimization: Role‑based specialization to improve efficiency across PEO, traditional employment, and mid‑market; underperforming BPAs removed to raise accountability and throughput .
- Net hiring assumptions: Modeling remains conservative vs historical 4–6%; improvement expected to be back‑half weighted in 2025 as sentiment improves .
Estimates Context
- Wall Street consensus (S&P Global) for Q4 2024 EPS and revenue could not be retrieved at the time of this analysis due to a rate‑limit error from S&P Global. As a result, we cannot provide a vs‑consensus comparison in this report.
- Company framing: Q4 adjusted EPS and adjusted EBITDA finished above the midpoint of Insperity’s expected range, and above the midpoints of prior Q4 guidance (EPS $(0.10)–$0.12; EBITDA $15–$27M) .
Key Takeaways for Investors
- Momentum into 2025: After a tough hiring backdrop in 2024, Insperity entered 2025 with positive January WSEE growth driven by record fall sales, strong retention (~99%), and +37% y/y new‑client WSEEs in Q4—supporting a return to WSEE growth this year .
- Near‑term profit headwinds: Management guides to elevated benefits cost trend (5%–6.5%) and a higher tax rate (≈$0.06 EPS headwind Q1/FY), with ~$62M Workday spend; operating plan for 2025 is “essentially flat” opex vs 2024, implying sequential opex declines through the year as savings are realized .
- Pricing discipline intact: Strong pricing kept GP per WSEE stable y/y in Q4 and slightly above internal expectations despite competitive conditions; tailored incentives protected long‑term premium pricing .
- Workday as a strategic catalyst: April 1 corporate tenant go‑live, subsequent platform updates, and co‑selling later in 2025 could support mid‑market retention and pricing power, with larger financial contribution expected in 2026 .
- Watch gross profit trajectory: Q4 GP dollars declined on lower WSEEs and higher opex; progress hinges on sustained WSEE growth and managing medical cost trends within guidance assumptions .
- Capital returns continue: Dividend maintained at $0.60 per share (payable Mar 27, 2025) alongside share repurchases in 2024, supported by adjusted cash of $134M at year‑end and $280M of revolver capacity .